Find a Specialist by Postal Code | Page 14 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Erica Warlick, MD Health Tree Foundation Minneapolis Minnesota United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Guillermo Sanz, MD, PhD Health Research Institute La Fe, Valencia, Spain Quatre Carreres Valencia Spain
  • Myelodysplastic Syndromes (MDS)
Matthew S. Davids, MD, MMSc Harvard Medical School Boston Massachusetts United States
  • Chronic Lymphocytic Leukemia (CLL)
Andrew Brunner Harvard Medical School Boston Massachusetts United States
  • Myelodysplastic Syndromes (MDS)
Robert Collins, MD Harold C. Simmons Comprehensive Cancer Center Dallas Texas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Alison R. Walker, MD H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida Tampa Florida United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Rami Komrokji, MD H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida Tampa Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
David Sallman, MD H. Lee Moffitt Cancer Center & Research Institute Tampa Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Eric Padron, M.D. H. Lee Moffitt Cancer Center & Research Institute Tampa Florida United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
David Gómez Almaguer, MD Gomez Almaguer Clinica de Hematologia Monterrey Nuevo Leon Mexico
  • Aplastic Anemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Myelodysplastic Syndromes (MDS)
Jorge Leguizamo, MD Georgia Cancer Specialists Atlanta Georgia United States
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Mikhail Kogan, MD George Washington Center for Integrative Medicine Washington DC District Of Columbia United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Hawk Kim, MD, PhD Gachon University Gil Medical Center Namdong-gu Incheon Metropolitan City South Korea
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
Carlo Dufour, MD G. Gaslini Research Children’s Hospital, Genova, Italy Genova Italy
  • Aplastic Anemia
  • Pediatric
Kazuhiko Ikeda, MD, PhD Fukushima Medical University School of Medicine Fukushima Japan
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myeloproliferative Neoplasms (MPN)
Laura Michaelis, MD, ABIM Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Ehab Atallah, MD Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Guang-Shing Cheng, M.D. Fred Hutchinson Cancer Research Center Seattle Washington United States
  • Graft Versus Host Disease (GVHD)
Catherine J. Lee, MD Fred Hutchinson Cancer Research Center Seattle Washington United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Sioban Keel, MD Fred Hutchinson Cancer Research Center Seattle Washington United States
  • Aplastic Anemia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)